BIOLASE (NASDAQ:BIOL) Now Covered by StockNews.com

StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report report published on Saturday. The brokerage issued a sell rating on the medical technology company’s stock.

BIOL has been the subject of several other research reports. Benchmark reaffirmed a “speculative buy” rating and set a $0.40 target price on shares of BIOLASE in a research note on Wednesday, October 2nd. Ascendiant Capital Markets lowered their price objective on shares of BIOLASE from $3.50 to $2.00 and set a “buy” rating for the company in a research note on Tuesday, September 3rd.

BIOLASE Price Performance

Shares of BIOL stock opened at $0.01 on Friday. The firm has a market cap of $228,837.95, a PE ratio of 0.00 and a beta of 0.67. The company has a 50-day moving average of $0.05 and a two-hundred day moving average of $0.10. BIOLASE has a 1-year low of $0.02 and a 1-year high of $1.94.

BIOLASE (NASDAQ:BIOL) last announced its earnings results on Thursday, August 8th. The medical technology company reported ($0.08) earnings per share for the quarter. The company had revenue of $11.56 million for the quarter. BIOLASE had a negative return on equity of 1,782.73% and a negative net margin of 41.65%.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in BIOLASE stock. Virtu Financial LLC grew its holdings in BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 143,537 shares of the medical technology company’s stock after purchasing an additional 131,248 shares during the quarter. Virtu Financial LLC owned 0.43% of BIOLASE worth $27,000 at the end of the most recent reporting period. Institutional investors own 8.79% of the company’s stock.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.